Saturday 17 October 2026 Export MIRM’s income statement to Excel — free account

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $521.3 million, up 54.7% from fiscal 2024. In the quarter to June 2026, revenue grew 37.9%, EPS fell 783.3%, free cash flow fell 681.5% and total debt rose 142.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

80.14 2.25 −2.73%

Follow MIRM

Alert me

Market cap: $5.4B
P/E: 0.0×
Fwd P/E: −6.0×
Dividend yield: —
F-score: 6/9
Altman Z: 4.42
Beneish M: −2.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		7.87	7.61	9.54	12.00
P/FCF ratio Full definition →		192.17	132.73	0.00	0.00
P/Operating CF Full definition →		93.55	653.56	(23.77)	(167.66)
P/B ratio Full definition →		12.71	12.60	22.42	0.00
Price to Tangible BV Full definition →		61.72	73.74	0.00	0.00
EV/Sales Full definition →		7.73	7.47	9.41	12.51
EV/EBITDA Full definition →		0.00	1,011.60	0.00	0.00
EV/Operating CF Full definition →		81.58	69.71	(31.35)	(34.02)
EV/FCF Full definition →		188.74	130.27	(26.47)	(28.24)
Quick Ratio Full definition →		3.01	2.46	1.90	2.62
Current Ratio Full definition →		3.31	2.67	2.09	2.86
Net Debt/EBITDA Full definition →		(7.27)	(37.84)	0.10	(8.92)
Debt/Assets Full definition →		39.40%	36.76%	34.82%	71.78%
Debt/Equity Full definition →		1.06	0.98	1.28	(71.97)
Asset Turnover Full definition →		0.65	0.69	0.72	0.70
Operating CF/Net income Full definition →		13.66	(1.06)	0.29	0.66
Capex/Depreciation Full definition →		(0.03)	(0.09)	(1.46)	(3.30)
Interest Coverage Full definition →		0.72	(1.27)	(218.33)	(16.25)
Research and Development Expense of Revenue Full definition →		32.30%	34.32%	515.51%	60.69%
Selling, General and Administrative Expense of Revenue Full definition →		46.55%	49.77%	60.25%	46.23%
Intangible Assets out of Total Assets Full definition →		0.30	0.31	0.29	0.24
Share Based Compensation of Revenue Full definition →		13.63%	12.77%	22.64%	17.35%
Graham Net Nets Full definition →		0.01	0.01	(0.01)	(0.06)
Graham Number Full definition →		0.00	0.00	0.00	7.33
Earnings Yield Full definition →		(1.16%)	(0.60%)	(14.72%)	(12.42%)
Free Cash Flow Yield Full definition →		0.52%	0.75%	(3.73%)	(3.69%)
Revenue per Share Full definition →		2.63	2.97	2.72	2.78
Operating CF per Share Full definition →		0.78	0.12	(3.89)	(0.70)
Capex per Share Full definition →		0.00	(0.01)	(0.18)	(0.39)
Free Cash Flow per Share Full definition →		0.78	0.11	(4.07)	(1.09)
Cash per Share Full definition →		7.42	7.64	6.56	6.92
Shareholders Equity per Share Full definition →		5.77	6.27	4.12	(0.16)
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		5.77	6.27	4.12	(0.16)
Free Cash Flow Full definition →		39.49	5.47	(239.43)	(69.27)
Working Capital Full definition →		370.22	343.89	296.61	413.52
Capital Expenditures Full definition →		(0.19)	(0.60)	(10.66)	(25.02)
Net Current Asset Value Full definition →		37.51	21.56	(78.99)	(419.09)
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.07	0.14
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		87.83	100.81	114.48	126.10
Average Payables Full definition →		10.86	12.12	35.52	20.54
Average Inventory Full definition →		22.81	23.65	23.97	24.36
Average Assets Full definition →		726.50	756.78	790.58	885.40
Average Common Equity Full definition →		262.04	270.17	237.88	122.37

Show all line items

Columns are period end dates

Stockrow Weekly